Pfizer stock
Business, News, US Markets

Pfizer (NYSE: PFE) Stock Drops Despite Positive Regulatory News on Hemophilia B Gene Therapy

/

Pfizer (NYSE: PFE) stock fell more than 2% on Thursday, even though Canadian regulators approved its Gene Therapy for Hemophilia […]

Pfizer (NYSE: PFE) Stock Drops Despite Positive Regulatory News on Hemophilia B Gene Therapy Read More »